In a pediatric first aid/CPR/AED course, participants learn how to prevent, recognize and respond to cardiac and breathing emergencies, use an automatic external defibrillator (AED), treat wounds and burns, and care for sudden illnesses in infants and children under age 12.
Montelukast (trade names Singulair, Montelo-10, and Monteflo and Lukotas in India, Arokast in Bangladesh and Pulmikast in Pakistan) is a leukotriene receptor antagonist (LTRA) used for the maintenance treatment of asthma and to relieve symptoms of seasonal allergies.ontelukast is a CysLT1 antagonist; it blocks the action of leukotriene D4 (and secondary ligands LTC4 and LTE4) on the cysteinyl leukotriene receptor CysLT 1 in the lungs and bronchial tubes by binding to it.
Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates insulin secretion. Marketed under the brand name Victoza, it is an injectable drug developed by Novo Nordisk for the treatment of type 2 diabetes. In 2015, Novo Nordisk began marketing it in the U.S. under the brand name Saxenda as a treatment for obesity in adults with at least one weight-related comorbid condition.